Skape Bio
PrivateLast Round
Pre Seed
Sep 22, 2025
Total Funding Raised
$1.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Skape Bio is a biotechnology company with a drug discovery platform designed for pharmaceutical companies to unlock G protein-coupled receptors. The company's AI-driven platform unites generative protein design, native receptor biology, and scalable in-cell screening, enabling drug developers to access unreachable therapeutic targets and achieve precise receptor modulation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skape Bio Comparables
Compare Skape Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SelekTx | 82% | |
| VRG Therapeutics | 82% | |
| Fusiomica | 79% |
Skape Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 22, 2025 |
Skape Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mission BioCapital | Pre Seed |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
$500K round led by Mission BioCapital
Skape Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Skape Bio's valuation, stock price, and market status.
Is Skape Bio a public or private company?
Skape Bio is a private company.
What is the current stock price of Skape Bio?
Skape Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Skape Bio worth (valuation)?
Valuation information for Skape Bio is not publicly available.
Can I buy Skape Bio stock?
Skape Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Skape Bio's last funding round?
Skape Bio's most recent funding round was Pre Seed on September 22, 2025.
Who are the main investors in Skape Bio?
Key investors in Skape Bio include Mission BioCapital, BioInnovation Institute.
Will Skape Bio IPO soon?
No public IPO plans have been announced for Skape Bio.
How can I track Skape Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Skape Bio's secondary market activity and sign up for updates.